3 Stocks That Big Investors Like /Are Buying

When investment pros such as Warren Buffett, George Soros and Leon Coopermanput their money behind a company, it’s worth noting — especially when they do it together.

Of course, Wall Street’s best and brightest aren’t always in agreement, and when they’re not, things can get pretty heated. Take, for example, Bill Ackman and Carl Icahn‘s epic showdown overHerbalife (HLF) or Dan Loeb’s sharp criticism of Warren Buffett.

Warren Buffett picked up a stake in 21st Century Fox (FOXA) in late 2014, and in 2015, he has continued to increase his position and now owns over 6.2 million shares.

During the first quarter of the year, Leon Cooperman joined the Oracle of Omaha in betting on FOXA with the purchase of 2.6 million shares, and Chase Coleman’s Tiger Global maintained its position of 16.8 million shares.

On June 11, news broke that Rupert Murdoch is preparing to step down as CEO of 21st Century Fox and hand over the reins to his sons, James and Lachlan. The company confirmed Tuesday that James will succeed his father as chief executive.

One interesting fact about how Murdoch’s exit will affect Buffett: Once Murdoch steps down, Buffett will increase his lead as the oldest CEO in the S&P 500

Adreas Halvorsen’s biggest new buy of the first quarter of 2015 was AIG (AIG – Get Report), of which he picked up 8.4 million shares valued at upwards of $460 million. Fellow hedge funder John Paulson picked up an even bigger stake in the insurance company, purchasing 14.6 million shares. Larry Robbins increased his position to 6.5 million shares, and Dan Loeb left his holdings untouched at 3.5 million shares.

In other words, AIG is pretty popular among Wall Street pros.
AIG made headlines Monday when a federal judge ruled that the U.S. acted beyond the bounds of its authority in its 2008 bailout of the company; however, the judge did not award any damages to former AIG chief executive, Hank Greenberg, who sought to win at least $25 billion for shareholders.

Through market close Wednesday, AIG’s stock has climbed more than 10% year-to-date.

The cheaper Chesapeake Energy (CHKGet Report) becomes, the more Carl Icahn buys — or that’s at least how it seems. The vociferous billionaire investor raised eyebrows in March when a regulatory filing revealed he had increased his stake in the energy company. He owns more than 73 million CHK shares, giving him an 11% stake.

Ray Dalio’s Bridgewater Associates also upped the ante in Chesapeake Energy this year. In the first quarter, the fund nearly doubled its position. It owns about 450,000 of the company’s shares.

Chesapeake, a producer of natural gas, oil and natural gas liquids, has been hit hard by falling oil prices. Through market close Wednesday, its stock has declined 60% over the past year, including about 38% in 2015 alone.

Analysts at Oppenheimer downgraded the stock to perform from outperform on June 11. “Based on the future strip benchmark oil and gas prices, we expect CHK to report losses of $544M this year and $833M next year, or $0.58 per share and $0.84 per share, respectively,” the firm said in an analyst note.

Cramer Says : Sell Apache

 

Apache Corp. (APAGet Report)
Market Cap: $22.3 billion
Sector: Energy/Oil & Gas Explorations & Production
TheStreet Ratings: Sell, D
Beta: 1.48
Year-to-date return: -5.8%

Apache Corporation, an independent energy company, explores, develops, and produces natural gas, crude oil, and natural gas liquids.

TheStreet Ratings said: “We rate APACHE CORP (APA) a SELL. This is driven by some concerns, which we believe should have a greater impact than any strengths, and could make it more difficult for investors to achieve positive results compared to most of the stocks we cover. The company’s weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity, weak operating cash flow, generally disappointing historical performance in the stock itself and feeble growth in its earnings per share.”

Highlights from the analysis by TheStreet Ratings Team goes as follows:

  • The company, on the basis of change in net income from the same quarter one year ago, has significantly underperformed when compared to that of the S&P 500 and the Oil, Gas & Consumable Fuels industry. The net income has significantly decreased by 2070.8% when compared to the same quarter one year ago, falling from $236.00 million to -$4,651.00 million.
  • Return on equity has greatly decreased when compared to its ROE from the same quarter one year prior. This is a signal of major weakness within the corporation. Compared to other companies in the Oil, Gas & Consumable Fuels industry and the overall market, APACHE CORP’s return on equity significantly trails that of both the industry average and the S&P 500.
  • Net operating cash flow has significantly decreased to $650.00 million or 71.65% when compared to the same quarter last year. In addition, when comparing the cash generation rate to the industry average, the firm’s growth is significantly lower.
  • Despite any intermediate fluctuations, we have only bad news to report on this stock’s performance over the last year: it has tumbled by 39.06%, worse than the S&P 500’s performance. Consistent with the plunge in the stock price, the company’s earnings per share are down 749.47% compared to the year-earlier quarter. Naturally, the overall market trend is bound to be a significant factor. However, in one sense, the stock’s sharp decline last year is a positive for future investors, making it cheaper (in proportion to its earnings over the past year) than most other stocks in its industry. But due to other concerns, we feel the stock is still not a good buy right now.
  • APACHE CORP has experienced a steep decline in earnings per share in the most recent quarter in comparison to its performance from the same quarter a year ago. The company has reported a trend of declining earnings per share over the past two years. However, the consensus estimate suggests that this trend should reverse in the coming year. During the past fiscal year, APACHE CORP swung to a loss, reporting -$13.07 versus $5.95 in the prior year. This year, the market expects an improvement in earnings (-$1.03 versus -$13.07).

Gold under pressure as investors await Fed for US rate outlook

Gold bars are stacked in safe deposit boxes room of the ProAurum gold house in Munich

Gold added to overnight losses to hover near $1,180 an ounce on Wednesday as investors waited for a Federal Reserve statement for clues on the timing of a U.S. interest rate hike.

Spot gold had eased 0.2 percent to $1,179.01 an ounce by 0655 GMT after dipping 0.4 percent in the previous session. Platinum fell to a six-year low of $1,068.75, while palladium dropped to its lowest since March 31.

All eyes will be on the Fed’s statement due at 1800 GMT after the Federal Open Market Committee’s two-day policy meeting. Fed Chair Janet Yellen’s news conference will also be monitored for pointers to the timing of the coming rate rise.

Also out after the meeting will be the committee members’ latest forecasts for economic growth and interest rates, both of which might be nudged lower.

Bullion has not made much headway in recent months because of uncertainty over the timing of the rate rise, which would reduce demand for non-interest-paying assets.

“Gold may find support at $1,165 if Yellen proves to be unambiguously hawkish tonight,” said Howie Lee, an analyst at Phillip Futures.

“The dollar is likely to be the beneficiary tonight,” he added.

A stronger greenback would hurt the dollar-denominated metal, making it more expensive for holders of other currencies while also curbing safe-haven demand.

The continuing Greek debt crisis is not spurring much safe-haven demand.

Prime Minister Alexis Tsipras accused Greece’s creditors on Tuesday of trying to “humiliate” Greeks with more cuts as he defied a growing drumbeat of warnings that Europe was preparing for his country to leave the euro. [ID:nL5N0Z21I7]

The unrepentant address to lawmakers after the collapse of talks with European and IMF lenders at the weekend was the clearest sign yet that the leftist leader has no intention of making a last-minute U-turn and accepting austerity cuts needed to unlock frozen aid and avoid a debt default within two weeks.

Gold is typically seen as a good bet at times of financial and economic uncertainty, but bids have failed to emerge in a robust way as expectations of a U.S. interest rate rise this year are weighing on the market.

The metal’s technical picture was also bearish, ScotiaMocatta analysts said.

Gold appears increasingly vulnerable to a break towards a recent low near $1,160 reached last month, they said.

Read more on protecting your portfolio profits at http://www.youroffshoremoney.com

Stocks To Avoid : Chesapeake Our Top Avoid In Natural Gas,

occupy wall street cartoon

 

These are this Thursday’s top analyst upgrades, downgrades and initiations.

Check out Seeking Alpha for the unending series of article seeking  to pick the bottom – in natural gas, shipping , drilling and compare that to our consistent  AVOID ratings:

Chesapeake Energy Corp. (NYSE: CHK) was downgraded to Perform from Outperform at Oppenheimer. That means that the firm now has no target to speak of, and the $13.06 closing price compares to a consensus price target of $15.67 and a 52-week range of $12.89 to $29.92. The downgrade was based on growing losses and a cash flow deficit.

Rite Aid Corp. (NYSE: RAD) was started as Outperform with a $10 price target (versus a $8.64 close) at Credit Suisse. The firm believes Rite Aid is one of the more compelling risk-reward profiles in the space and that it has a compelling M&A potential.

Toll Brothers Inc. (NYSE: TOL) was raised to Outperform from Neutral and the target price was raised to $42 from $40 (versus a $36.81 close) at Credit Suisse. The firm believes that investors underappreciate its earnings potential, and the firm raised estimates to reflect the updated City Living pipeline.

Transocean Ltd. (NYSE: RIG) was started as Underweight with a price target of $14 (versus a $19.08 close) at Barclays. Transocean’s consensus price target is $14.17, and the 52-week range is $13.28 to $46.12.

Harley-Davidson Inc. (NYSE: HOG) was downgraded to Neutral from Outperform with a price target cut to $57.00 from $74.00 (versus a $54.69 close) at Wedbush. Harley-Davidson has a consensus price target of $66.00 and a 52-week range of $53.04 to $72.37.

 

Books Every Gold Gold Investor Must Read – go to Amazon.com books to start your library

 

A controversial effort to overcome  the emotion and fear that often drives the price of precious metals and certainly drives perpetual interest in gold.

 

Barry Eichengreen’s Golden Fetters is the classic must-read on gold. It has been near-two decades but it is still the required own. Eichengreen’s tome changed the discussion. Before Golden Fetters there was no authoritative text that brought together the economics and finance of what gold meant for society. Warning: Eichengreen writes in a deceptively dense fashion. It will take you longer than you think to wade through the 400+ pages. It is worth it. It helps that the young Eichengreen of 1996 has become a definitive international economist. A Berkeley Bonus: check out his concise Exorbitant Privilege.

 

I recently talked about Peter Bernstein’s Against the Gods. That one gets the fame and acclaim which unfortunately hides his other great efforts. One of those other works isThe Power of Gold. The book combines an exploration of our beliefs in gold with a quick and measured history. Peter Bernstein does what he does in every book; makes you furious that there are no more pages to turn. It is hugely readable and is without question the one-volume to move you beyond the gold-bear/gold-bug parallax. Bernstein does economic history like no one else and brilliantly tosses in myth and mystery when writing on gold.

In the great tradition of gold writing there are those who worry. Agree or disagree, James Rickards owns the high ground on why we should worry about the many swans of our international financial system. In the great tradition of Harry Browne (and yes, I read them all), The Death of Money informs on why we should worry. It makes for must reading for gold-bugs and those sitting on top of the wall of worry. Far more, optimists will frame and reframe their optimisim with a careful reading of Rickards. How can you not worry if you don’t understand why the worriers worry?

Books on the end of the dollar/Fed/WallStreet as we know it are a devalued dime a dozen. Some are earnest, most shrill and few dead wrong over many decades. Rickards is different. He writes clear, cogent and direct.

One important note: I am clearly in the things-will-work-out-camp. The great savior of the financial system is always ‘compensating factors’ and adjustment at both the macro- and micro-economic level. See this classic paper from William Cline on over-wrought worry in foreign exchange.

So, here are three constructive efforts on all things gold. You may not want to ‘buy gold’ but buying the best books about gold is a great investment.

Our First Choice :

Compound Interest and an early start $16,000 = Millions

Ben and Arthur were friends who grew up together. They both knew that they needed to start thinking about the future. At age 19, Ben decided to invest $2,000 every year for eight years. He picked investment funds that averaged a 12% interest rate. Then, at age 26, Ben stopped putting money into his investments. So he put a total of $16,000 into his investment funds.

Now Arthur didn’t start investing until age 27. Just like Ben, he put $2,000 into his investment funds every year until he turned 65. He got the same 12% interest rate as Ben, but he invested 23 more years than Ben did. So Arthur invested a total of $78,000 over 39 years.

 

Trading Alert : CONVALO HEALTH INTERNATIONAL CORP(CXV:TSXV, CA)

Convalo Executes Final Binding Purchase Agreements for Hollywood Detox and ARTS; Increases Run Rate Revenues to Over $23 Million and Adjusted EBITDA to Over $5.5 Million

LOS ANGELES, CALIFORNIA–(Marketwired – June 10, 2015) –

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN

Convalo Health International, Corp. (Convalo) (TSX VENTURE:CXV), an acquisition-oriented company focused on rolling up the US addiction rehabilitation market, announced that it executed today a final binding Purchase Agreements for the acquisition of Hollywood Detox Center (Hollywood Detox) and Accredited Rehab and Treatment Services (ARTS), two profitable southern California companies.

Hollywood Detox and ARTS are behavioral health facilities offering detox and residential treatment services for both men and woman in and around the Hollywood and central Los Angeles area.

When added to the outpatient treatment services currently offered by BLVD Treatment Centers, Convalo now has a full service behavioral health platform spanning Hollywood and Central Los Angeles capable of treating patients at every level of the addiction treatment continuum. The combined annual revenue run-rate for this Hollywood and Central Los Angeles business now exceeds $23,000,000 and annualized run rate Adjusted EBITDA now exceeds $5,500,000.

By the end of the year, Convalo will expand this platform to include additional detox and residential treatment centers for both men and women on the west side of Los Angeles.

Three of the companies’ top level executives, Keith Fowler, Brent Ortner and Ryan Newport, will remain on after the transaction and are expected to play key roles in Convalo moving forward.

Terms of the Acquisition

Management has reported combined trailing 12-month revenues in excess of $14 million and Adjusted EBITDA in excess of $3.6 million. This acquisition is expected to increase Convalo’s revenues by over 150% and Adjusted EBITDA by more than 220%.

According to the Purchase Agreements, Convalo will acquire the businesses for a mix of cash and stock. Convalo will pay a total of $7,937,500 in cash and up to 8,000,000 shares or under 3% of the fully diluted shares of the company. Post-acquisition, Convalo will have over $21,500,000 in cash on the balance sheet with which to make further acquisitions. Convalo has no debt.

“We are now a fully established addiction services company in the heart of Los Angeles with over $23 million in revenues and significant profitability” said Mr. Dalsin, Chairman and CEO of Convalo. “While there is a significant positive impact on revenue and profits, this acquisition really only covers Hollywood and Central Los Angeles.  acquisition of the management team gives us the ability to create a similar business in terms of revenues and

CONVALO HEALTH INTERNATIONAL CORP(CXV:TSXV, CA)

0.60CADIncrease0.02(3.45%)Volume: 
Below Average

QUOTE DETAILS

Open 0.6000 P/E Ratio (TTM)
Last Bid/Size 0.6000 / 231 EPS (TTM) -0.02
Last Ask/Size 0.6100 / 211 Next Earnings
Previous Close 0.5800 Beta
Volume 975,314 Last Dividend
Average Volume 1,198,365 Dividend Yield
Day High 0.6100 Ex-Dividend Date
Day Low 0.5700 Shares Outstanding 159.1M
52 Week High 0.8200 # of Floating Shares 154.8618M
52 Week Low 0.2300 Short Interest as % of Float
DRIP Eligible No

Patient Home Monitoring (PHM) Update Aquisition

TSX VENTURE : PHM

June 09, 2015 15:41 ET

PHM Announces Execution of Final Binding Purchase Agreement to Acquire Louisiana-Based Sleep Management

Increases Annualized Run-rate Revenue to over $115,000,000 and Annualized Run-rate Adjusted EBITDA to over $30,000,000

LOS ANGELES, CALIFORNIA–(Marketwired – June 9, 2015) –

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN.

Patient Home Monitoring (PHM) (TSX VENTURE:PHM), a profitable company focused on rolling-up annuity-based healthcare service companies in the U.S. and Canada, announced that today it executed a final, binding purchase agreement to acquire Sleep Management, a company operating in 19 states and headquartered in Louisiana.

The business had annualized revenues of more than $42,500,000 and Adjusted EBITDA of more than $18,000,000. PHM retained its external auditor to conduct an independent financial review of Sleep Management.

When combined with existing operations, PHM expects annualized run-rate revenue to exceed $115,000,000 and Adjusted EBITDA to exceed $30,000,000, before any potential revenue from organic growth and cross selling.

Sleep Management currently provides home based medical services in 19 states across the US. The Company focuses on providing high margin ventilators to patients with chronic pulmonary obstructive (COPD) conditions. The business has a substantial amount of active patients that PHM will now offer new services and products. PHM plans to start immediately cross-selling its existing service lines across all of the acquired locations.

Final Terms of the Agreement

PHM will increase revenues by nearly 60% and increase EBITDA by more than 150%. Total consideration paid is $36 million in cash and 42.75 million shares, representing less than 15% of PHM’s total outstanding common shares. The shares will be released from holds over a three year period. Closing of the acquisition will be subject to approval by the TSX Venture exchange and other standard conditions.

All three owners are taking a portion of their consideration in stock and will stay on with PHM as senior executives post-acquisition.

“We wanted to focus on closing our largest deal first,” said Michael Dalsin, Chairman of the Board for PHM. “When you take into consideration the size of this company, in terms of patients, geographical spread, growing revenues, and significant profits, we have doubled the run rate profitability of PHM overnight with this transaction. It gives PHM immediate access to more than a dozen new states to start cross-sell additional services. Additionally, we have two more LOIs we are working to close with combined trailing 12 month revenues of $35 million, along with several smaller deals that have combined revenues of $15 million.”

“When closed, this acquisition will be EPS accretive. It is expected to increase run rate EBITDA by more than 150% before any organic growth,” continued Mr. Dalsin. “We continue to invest in M&A activities and are, with each additional deal, getting closer to our exit revenue run rate goal for 2015 of $175 million.”

Additionally, the PHM Board of Directors approved the issuance of performance stock compensation in the form of options to several key personnel. PHM issued (a) 3,000,000 options each to Michael Dalsin and Roger Greene as Chairman and Vice Chairman, respectively; (b) 500,000 options to Nitin Kaushal as non-executive Director; and (c) 250,000 options to David Costine as non-executive Director; all options are issued at a market strike price of $1.46.

The transaction with Sleep Management is arms length.

About PHM

The explosive growth in the number of elderly patients in the US healthcare market is creating pressure to provide more efficient delivery systems. Healthcare providers, such as hospitals, physicians and pharmacies, are seeking partners that can offer a range of products and services that improve outcomes, reduce hospital readmissions, and help control costs. PHM fills this need by delivering a growing number of specialized products and services to achieve these goals. PHM is a positive cash flow and profitable company that serves patients with heart disease and other chronic health conditions, this operation is a platform for acquisitions and organic growth. PHM is focused on a highly fragmented and developing market of small privately-held companies servicing chronically ill patients with multiple disease states caused mainly by age and obesity. Because of the new and highly fragmented nature of the market, PHM is actively working to identify and evaluate profitable, annuity-based companies to acquire their patient databases and technical expertise at favorable prices. PHM’s post acquisition organic growth strategy is to increase annual revenue per patient by offering multiple services to the same patient, consolidating the patient’s services and making life easier for the patient. The expected result is growing EPS with each acquisition and growing revenue and profits from the cross selling efforts.

Restaurant Stocks to Buy

7 Restaurant Stocks to Buy: Starbucks (SBUX)

Starbucks185 7 Restaurant Stocks to Feed Your Appetite for ProfitsOne of most famous poster children of discretionary spending is Starbucks(SBUX). Most people still see this as the trendy coffee spot, but over the past few years, SBUX has begun to up its food game.

It’s kind of reverse engineering a casual dining model from a cafe, whereas Panera (PNRA) built a casual dining restaurant with a cafe feel. What it does for SBUX is help boost revenue per customer and extend its revenue stream across the day and evening. The food is fast but quality and surprisingly reasonably priced.

You won’t get a half-pound burger for $5, but you can get grilled cheese, a panini, healthy bistro boxes with hummus and fruit, as well as wraps. All quick, all healthy and all fresh.

This isn’t going to be a gamechanger for SBUX, but it does give the stores more dimension than just a morning place to grab a coffee, or make an afternoon run for an iced macchiatto.

In the last six months the stock is up more than 25%, and there’s a lot of good news that could kick it higher

Darden Restaurants (DRI)

Darden185 7 Restaurant Stocks to Feed Your Appetite for ProfitsDarden Restaurants (DRI) was famous for its Red Lobster and Olive Garden restaurants. But it sold Red Lobster and is now in the midst of updating Olive Garden.

The company also owns LongHorn Steakhouse, Bahama Breeze, Seasons 52, The Capital Grille, Eddie V’s Prime Seafood, Wildfish Seafood Grill and Yard House. Many of these are more upscale than their sister shop Olive Garden, and that seems to have been the recent trend in acquiring and growing these brands.

Restaurant stocks are great barometers for the economy. When times are good restaurant stocks soar; when times are bad, only the strong survive. And DRI is certainly one of the savviest restaurant stocks out there.

Last year was tough on DRI but it has turned things around after the sale of Red Lobster and it’s firing on all cylinders again. Net profit margin has more than doubled last year; return on assests has tripled.

The stock is up almost 30% in the past year.As the economy regains momentum and more business start to spend DRI is in great shape to reap the benefits. Add to all that, DRI has a nice dividend around 3.4%.

Cracker Barrel (CBRL)

CrackerBarrel185 7 Restaurant Stocks to Feed Your Appetite for ProfitsCracker Barrel (CBRL) is one of the great American restaurant chains, especially for travelers. The first one was built in Lebanon, Tennessee, between Nashville and Knoxville by Dan Evins in the late 1960s. His idea was simple; give travelers good homestyle food in a homestyle setting once they get off the road for bit.

The first one opened in September 1969. By 1977 there were 13, from Tennessee to Georgia. Today there are more than 600 in 42 states.

Sales for restaurants open for at least a year (a key measure in this market) were up 5% in the most recent quarter. It also raised its dividend and declared a special $3 a share dividend on Aug. 5, for shareholders as of July 17.

CBRL has a nearly 3% dividend, which is certainly a nice bonus to its 46% stock price move in the past year.

The biggest surprise is, most Americans have yet to hit the highways, so its recent quarterly surprise suggests that coming quarters will also be strong as well.

Jack In The Box (BOX)

jack in the box jack stock 185 7 Restaurant Stocks to Feed Your Appetite for ProfitsJack In The Box (JACK) is a classic West Coast burger joint that over the decades established a national foothold. But it’s always been a quirky chain, without the spark and brimstone of McDonald’s (MCD) or Burger King(BKW). But it’s a major player; it just doesn’t act like it.

Let’s just say it’s the class clown of quick-service restaurants. It also runs Mexican eatery Qdoba, which is a new “fresh and fast” style of burritos, tacos and salads. Combined the operation has 2,888 stores across the country.

Recently Qdoba has been the engine of growth for the company. In the first quarter, same store sales were up 14% and the average check was up 9%.

JACK stock overall was up 4.4% in same store sales for the quarter. Some of the difference could be the fact that since JACK specializes in hamburgers and the cost of beef rose, its margins were a bit tighter than Qdoba, which has more non-beef options.

Qdoba is a great asset for JACK since it offsets the classic burger joint fare by adding products and a niche that can draw in an entirely different kind of customer — and is doing so.

Texas Roadhouse (TXRH)

texas roadhouse txrh stock 185 7 Restaurant Stocks to Feed Your Appetite for ProfitsTexas Roadhouse (TXRH) is a family-oriented oriented steakhouse; theOutback Steakhouse of the American west. This isn’t a bargain spot, it’s a mid-priced restaurant focused on family … and steak.

It’s working. It reported its most recent quarterly numbers in early May and TXRH is growing top line and bottom line. This is a classic restaurant stock in growth phase mode.

TXRH has 450 restaurants and expects to add 30 more by the end of 2015, including some of its new Bubba 33 sports bars in select markets.

Revenues were 16% for the quarter, operating income grew 21% and net income jumped 22%. Sales growth was led the industry — 8.9% for company restaurants and 8% for franchise restaurants.

The stock is up 38% in the past year, but the current numbers are very encouraging, considering it hit these numbers in bad weather with prices for many inputs spiking. The spring and summer look very promising indeed.

TXRH also has a nearly 2% dividend. Even as it places its money on growth, that’s a good shareholder-friendly sign.

Sonic (SONC)

sonic sonc stock logo 185 7 Restaurant Stocks to Feed Your Appetite for ProfitsSonic (SONC) has been one of the winners from the devolution of McDonald’s. As MCD has lost market share, SONC has gained it. This hold true for a number of other burger joints, both large and small.

The thing is, it’s easier to increase market share if you’re SONC than it is if you’re say, Wendys (WEN).

And this has helped boost SONC’s numbers as well as its stock price. The stock is up almost 40% in the past year. But as the fast-food model changes, it’s companies like SONC that will be the winners.

The thing about SONC is, this isn’t some retro fad; this is the real deal. From the company’s website:

“Sonic revolutionized the ordering process in 1953 by using curbside speakers that allowed customers to place food orders without ever leaving their cars. This technology spawned the slogan “Service at the Speed of Sound,” which translated to one word: Sonic. Troy Smith Sr. aptly changed the name from Top Hat to Sonic Drive-In in 1959.”

There’s plenty of opportunity here for SONC and having such a long history in the business but having such a enduring and unique footprint should serve the companies 3,500 restaurants well in coming quarters

Denny’s (DENN)

DennysLogo 7 Restaurant Stocks to Feed Your Appetite for Profits“To serve the best cup of coffee, make the best donuts, give the best service, offer the best value and stay open 24 hours a day.” That was the commitment of the owner of Harold Butler when he opened Danny’s Donuts in LA in 1953.

The name changed, but the commitment never has. Denny’s (DENN) now has 1,700 restaurants across the country.

And this classic all night diner with the bargain meals has made a shift to upgrade its restaurants as well as its menus for a generation of nighthawks. And it’s working. Same store sales were up 7.2% in the first quarter and the company is saying that more people are shifting away from the value meals and buying up on the menu.

That is indicative of two things: they customers like the food they’re getting and are willing to try more expensive items; and customers have more money to try new things beyond the reliable bargains.

Either way, it’s a bullish sign. The stock is up 62% in the past year and there’s plenty left where that came from.

Trading Alert : PHM Gains on volume in the last 30 minutes

 

PATIENT HOME MONITORING CORP(PHM:TSXV, CA)

1.58CADIncrease0.11(7.48%)Volume: 
Below Average
As of 05 Jun 2015 at 3:47 PM EDT.

 


QUOTE DETAILS

Open 1.48 P/E Ratio (TTM)
Last Bid/Size 1.57 / 557 EPS (TTM) -0.05
Last Ask/Size 1.58 / 210 Next Earnings
Previous Close 1.47 Beta -0.21
Volume 993,612 Last Dividend
Average Volume 1,424,839 Dividend Yield
Day High 1.58 Ex-Dividend Date
Day Low 1.45 Shares Outstanding 236.4M
52 Week High 2.01 # of Floating Shares 214.4527M
52 Week Low 0.2550 Short Interest as % of Float
DRIP Eligible No